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INTRODUCTION
Nowadays, both two-dimensional (2-D) echocardiography
and fluoroscopy have become the preferred imaging modal-
ities to guide endomyocardial biopsy (EMBx) (1-3). In con-
trast to traditional fluoroscopic guidance, 2-D echocardiog-
raphy in addition to fluoroscopic guidance facilitates the direct
control of the bioptome in the right ventricle, and therefore,
reduces the risk of damage to the heart structures. Two-D
echocardiography also permits one to detect a perforation at
the moment of its occurrence and to manage the cardiac tam-
ponade immediately.
Although 2-D echocardiography guided EMBx is useful
for reducing the development of serious complications and
their management, the routine use of EMBx in the diagno-
sis of diverse cardiac pathologies has not gained widespread
acceptance in Korea due to the possible complications relat-
ed to the procedure. Thus, not much information is available
on the rate and kind of complications related to EMBx. In
this study, we prospectively evaluated 90 consecutive patients
who underwent 2-D echocardiography guided transfemoral
right ventricular EMBx to determine the incidence, nature,
and subsequent management of the complications related
to the EMBx.
MATERIALS AND METHODS
Selection of patients
The study group consisted of 90 consecutive patients who
underwent EMBx at Kyungpook National University Hos-
pital between March 2002 and November 2005. A history,
physical examination, routine laboratory studies, chest radio-
graphy, 12-lead ECG and 2-D echocardiography were per-
formed on all patients. In selected cases, a Holter ECG, sig-
nal-averaged ECG, exercise-ECG, dobutamine echocardiog-
raphy and cardiac MRI were also obtained. In a large num-
ber of patients, coronary angiography, cardiac catheterization,
and ventricular tachycardia induction were also carried out
simultaneously. Usually the EMBx was performed as the final
diagnostic tool for confirming and making a differential diag-
nosis of various cardiac pathologies. The protocol of this study
was approved by the ethics committee of the hospital and
written informed consent was obtained from each patient.
Endomyocardial biopsy
Intravenous access was made through the right femoral
vein as right heart catheterization and ventricular tachycar-
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Endomyocardial biopsy (EMBx) is a useful tool for diagnosing various cardiac patho-
logies. However, the routine use of EMBx has not gained widespread acceptance
due to the possible complications related to the EMBx. Thus, not much information
is available on the complications related to the EMBx. We prospectively evaluated
90 consecutive patients who underwent 2-D echocardiography guided transfemoral
right ventricular EMBx at Kyungpook National University Hospital between March
2002 and November 2005 to determine the incidence, nature and subsequent man-
agement of complications related to EMBx. The clinical diagnoses before the EMBx
were arrhythmogenic right ventricular dysplasia in 54, dilated cardiomyopathy in 19,
Brugada syndrome in 9, myocarditis in 6 and miscellaneous in 2 patients. The over-
all major complication rate was 5.6% and no procedure-related mortality occurred.
Myocardial perforation (n=3), which was the most frequent complication, did not
progress to cardiac tamponade requiring pericardiocentesis in any patient. Hemody-
namically unstable ventricular tachycardia occurred in 1 patient. New and persis-
tent right bundle branch block occurred in another. Our findings suggest that 2-D
echocardiography guided transfemoral right ventricular EMBx is a relatively safe
procedure. 
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dia induction were planned concomitantly during the EMBx.
The right femoral vein was cannulated using the Seldinger
technique. The puncture needle remained in the vein and a
0.032 inch guide wire was inserted through it. An 8 Fr Mullin
sheath and dilator (Medtronic, Minneapolis, MN, U.S.A.)
were then inserted over the wire. A 5.5 Fr 104 cm bioptome
(Cordis, Miami, FL, U.S.A.) was inserted through the sheath.
Two-D echocardiography was used to confirm the position
of the bioptome in the right atrium and right ventricle. For
ideal visualization of the instruments both in the right atri-
um and ventricle, an apical 4 chamber view, subcostal view,
and parasternal short axis view were used. As it passed across
the tricuspid valve, 2-D echocardiography was used to con-
firm that the direction of the bioptome was toward the right
side of the interventricular septum. Two-D echocardiographic
monitoring was carried out with a System Five
� (GE Vingmed
Ultrasound, Horten, Norway) with a 2.5 MHz probe. Once
contact with the endocardium was confirmed by echocardio-
graphy, the bioptome was withdrawn 1 to 2 cm, its jaws were
opened and advanced slowly to engage the endocardium.
Gentle forward pressure was maintained while the jaws were
closed. The bioptome containing the specimen was removed
by gentle traction on the shaft. Two to 8 samples were obta-
ined from each patient mainly from the right ventricular sep-
tum. However, in a small number of patients, the right ven-
tricular outflow tract or right ventricular apex were biopsied
to increase the sensitivity in cases of suspected arrhythmogenic
right ventricular dysplasia (ARVD) or Brugada syndrome. 
Complications 
The major complications associated with the EMBx were
divided to 4 categories (2, 4): complications related to venous
cannulation, abnormalities of the heart rhythm, conduction
abnormalities, and mechanical damage to the heart structures.
Minor chest discomfort after the EMBx, although the relation
was uncertain, was also evaluated.
RESULTS
Patient characteristics 
A total of 90 patients underwent EMBx from March 2002
to November 2005 (Table 1). They were 42±13 yr old and
60 were male. Their clinical diagnoses before the EMBx were
ARVD (60.0%), dilated cardiomyopathy (21.1%), Brugada
syndrome (10.0%), myocarditis (6.7%), hypertrophic cardio-
myopathy (1.1%), and exercise-induced sustained ventricu-
lar tachycardia (1.1%) (Table 2). The right femoral vein was
used in all cases. The number of specimens taken was 2 to 8
(mean: 4.6±1.4). The primary site of the EMBx was the
right ventricular septum (93.3%). The right ventricular out-
flow tract was biopsied in 5 cases. In 1 case with dilated car-
diomyopathy, a septal wall biopsy was technically difficult,
so the right ventricular apex was mainly biopsied. Coronary
angiography (96.7%) and ventricular tachycardia induction
(68.9%) were carried out before the EMBx in the majority
of the cases. The final EMBx reports were as follows; ARVD
(32.2%), undetermined type cardiomyopathy (13.3%), dilat-
ed cardiomyopathy (8.9%), myocarditis (6.7%), fibrosis only
(1.1%), and no diagnostic abnormality (37.8%).
Complications
Our overall major complication rate was 5.6% and no pro-
cedure related mortality was observed (Table 3). The most
frequent complication was perforation (n=3), and it did not
progress to cardiac tamponade requiring pericardiocentesis
in any cases. Hemodynamically unstable sustained ventricu-
Data are expressed as mean values±SD or the number of patients.
LVEF, left ventricular ejection fraction; PCWP, pulmonary capillary wedge
pressure; RV, right ventricle; RVOT, right ventricular outflow tract.
Age (yr) 42±13
Male 60
LVEF by echocardiography (%) 50±15
Right ventricular pressure (mmHg)
Systolic 32±10
Diastolic 4±3
PCWP (mmHg) 14±7
No. of biopsy specimens 4.6±1.4
Biopsy site
RV septum 84
RVOT 3 
RV septum+RVOT 1
RV apex 1
RV septum+RVOT+RV apex 1
Table 1. Clinical characteristics of the patients
ARVD, arrhythmogenic right ventricular dysplasia; DCMP, dilated car-
diomyopathy; HCM, hypertrophic cardiomyopathy; VT, ventricular tachy-
cardia.
No. %
Clinical diagnosis before the EMBx
ARVD 54 60.0
DCMP 19 21.1
Brugada syndrome 9 10.0
Myocarditis 6 6.7
HCM 1 1.1
Exercise-induced VT 1 1.1
Final EMBx report
No diagnostic abnormality 34 37.8
ARVD 29 32.2
Cardiomyopathy, type undetermined 12 13.3
DCMP 8 8.9
Myocarditis 6 6.7
Fibrosis 1 1.1
Table 2. Clinical diagnosis before the endomyocardial biopsy
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lar tachycardia requiring direct current cardioversion occurred
in 1 patient. New and persistent right bundle branch block
occurred in another. No complications related to the venous
cannulation occurred in our series.
Arrhythmias
Hemodynamically unstable sustained ventricular tachycar-
dia occurred in 1 patient. He was admitted to undergo an
electrophysiological study and catheter ablation for paroxys-
mal supraventricular tachycardia. In the catheterization room,
unexpected and recurrent ventricular fibrillations occurred
several times during the insertion of the catheters and pacing.
Two days after the successful catheter ablation of an atrioven-
tricular reentrant tachycardia, ventricular tachycardia induc-
tion and an EMBx were performed in order to rule out any
occult cardiomyopathy. After ventricular tachycardia induc-
tion and angiography were carried out, an EMBx was per-
formed at the right ventricular septum. Hemodynamically
unstable ventricular tachycardia developed during the sec-
ond sampling and direct current cardioversion was applied
to restore sinus rhythm. Two-D echocardiography showed
no accumulation of pericardial effusion. No ventricular tachy-
cardia or fibrillation recurred after the EMBx.
Conduction abnormalities
New and persistent right bundle branch block occurred
just after the EMBx in 1 case. His clinical diagnosis was dilat-
ed cardiomyopathy and the ECGs recorded before and dur-
ing the EMBx exhibited sinus tachycardia without bundle
branch block. The EMBx specimens were obtained from near
the apex, and no hemodynamic changes or chest pain occurred
during the procedure. However, the ECGs recorded just after
the procedure, revealed a right bundle branch block. His ECG
did not progress to complete heart block and his general con-
dition remained stable with no intervention.
Cardiac perforation
Echocardiographic evidence of perforations was obtained
in 3 subjects (Table 4). The ventricular tachycardia induction,
coronary angiography, right heart catheterization, and right
ventriculography were all performed before the EMBx. In the
initial echocardiography just before the EMBx, there were
no pericardial effusions. The pericardial effusions developed
just after the EMBx, so we regarded them as perforations
related to the EMBx. The right ventricular septum was the
primary site for the EMBx in 2 of those patients. However,
the EMBx was performed at the right ventricular outflow
tract to increase the sensitivity of the EMBx in the other. The
clinical diagnoses before the EMBx of those patients were
ARVD (n=2) and Brugada syndrome (n=1). Two-D echocar-
diography revealed an accumulation of the pericardial effu-
sion immediately after the procedure in all 3 cases. The effu-
sions increased up to a maximum diameter of 6 mm with no
significant hemodynamic changes. Close observation with
hemodynamic monitoring was carried out and none of them
progressed to a cardiac tamponade and the effusions resolved
over several days. 
Minor abnormalities after the EMBx
Some abnormal symptoms or signs developed after the
EMBx. Those abnormalities were nonspecific, transient, and
may not have been related to the EMBx. Six patients (6.7%)
complained of chest discomfort after the EMBx. The nature
of the chest discomfort was both diverse and nonspecific.
Although 2-D echocardiography during and after the EMBx
did not show any accumulation of the pericardial effusion,
we regarded the chest discomfort as a possible sign of a per-
foration and carried out a close observation. The atypical chest
discomfort subsided spontaneously after several hours. How-
ever, acetaminophen was prescribed for relief of the chest dis-
comfort in 1 case.
Two patients (2.2%) developed cold sweats, nausea, vom-
iting, and hypotension several hours after the EMBx. The
laboratory studies, ECGs, and 2-D echocardiography revealed
no significant abnormalities. In the first patient, sinus brady-
cardia (minimum heart rate 38 beats/min) was accompanied VT, ventricular tachycardia; RBBB, right bundle branch block.
No. %
Major complications
Sustained VT 1 1.1
RBBB 1 1.1
Perforation 3 3.3
Minor abnormalities 
Chest discomfort 6 6.7
Hypotension 2 2.2
Non-sustained VT 1 1.1
Headache 1 1.1
Fever 1 1.1
Table 3. Complications of the endomyocardial biopsy 
Case Age (yr) Clinical diagnosis Biopsy site
No. of 
specimens
Amount of the PE Pericardiocentesis Sex
1 56 Female ARVD RVOT 4 Small Not  done
2 25 Male Brugada septum 5 Small Not done
3 56 Male ARVD septum 6 Small Not done
Table 4. Clinical data of 3 patients with perforations
PE, pericardial effusion; ARVD, arrhythmogenic right ventricular dysplasia; RVOT, right ventricular outflow tract.992 J. Han, Y. Park, H. Lee, et al.
with hypotension. Projectile vomiting after food intake occu-
rred before the hypotension and bradycardia, so we thought
an increased vagal tone was the cause in that patient. Intra-
venous atropine and hydration with normal saline improved
general condition. The second patient complained of hunger
and cold sweats with the development of hypotension (mini-
mum blood pressure 63/30 mmHg). However, she had main-
tained a fasting state for many hours before the EMBx and
was tired with stress and insomnia. Intravenous hydration
and oral feeding was used to restore her blood pressure and
general condition. One patient developed nonsustained ven-
tricular tachycardia a few hours after the EMBx and another
complained of a severe headache during and after the EMBx.
A neurological examination and brain imaging study includ-
ing a brain CT and MRI revealed no abnormalities and his
symptoms were relieved with analgesics. A transient fever
developed in another case with no abnormal findings in the
routine studies. The fever subsided without any medication. 
DISCUSSION
Although the histological and biochemical analyses of the
heart tissue obtained by an EMBx is the most likely tech-
nique to advance our understanding of various myocarditis
and cardiomyopathies (5-7), some serious complications that
might endanger one’s life also have long been noted (4, 8).
In fact, some believe that an EMBx may not be the appropri-
ate diagnostic strategy in unknown cardiomyopathy due to
the associated risks of major complications such as ventricular
wall perforation (9). However, there are some patients whose
diagnoses remain unclear even after extensive noninvasive
evaluations and we may need histologic confirmation to make
a proper diagnosis, differential diagnosis and risk stratifica-
tion of the patients (5). This study was from a single center
and all the EMBx procedures were unrelated to heart trans-
plantations, thus, we believe that our results may reflect the
real situation of the complications related to EMBx proce-
dures.
Four categories of complications might occur in association
with an EMBx (2, 4). The first includes complications related
to venous cannulation. Over half of the complications such
as an incidental arterial puncture, bleeding, hematoma, vaso-
vagal reaction, or rarely, a pneumothorax when the internal
jugular approach is used may occur during the venous can-
nulation (3, 5, 10). When compared with the internal jugu-
lar vein, the femoral venous approach has the risk of a deep
vein thrombosis and subsequent pulmonary embolism due
to the use of longer sheaths and the required immobilization
after the procedure (11). However, we did not experience any
serious complications in our series. We also could cannulate
femoral vein with no difficulty in all cases probably due to
the relatively large diameter of the femoral vein.
The second category is comprised of abnormalities of the
heart rhythm. The heart rhythms in patients with a prior his-
tory of arrhythmias were reported to have a tendency to be
exacerbated by endocardial irritation induced by the biop-
tome (2, 4, 12, 13). Supraventricular tachycardia has been
known to be most frequently observed arrhythmia during
EMBx (4). However, the development of ventricular tachy-
cardia was also reported (4, 5). In our series, 1 patient devel-
oped sustained ventricular tachycardia during the EMBx. Even
though he had only a history of documented paroxysmal sup-
raventricular tachycardia, ventricular fibrillation was repeat-
edly induced during the electrophysiologic study and susta-
ined ventricular tachycardia developed during the EMBx. The
arrhythmogenic irritation caused by the bioptome under a
high sympathetic tone may have been the cause of these arr-
hythmias in this young man. We think that having a history
of certain types of arrhythmias does not guarantee that only
the same type of arrhythmia will occur during the EMBx and
the operator must be prepared to manage any kind of arrhyth-
mia during the EMBx. 
The third category is comprised of conduction abnormali-
ties. Rarely, right bundle branch block may be created or com-
plete heart block may result in patients with a preexisting
left bundle branch block because the conduction system in
the right ventricular septum may be damaged by the biop-
tome during the EMBx (4, 12, 14). Most conduction abnor-
malities related to the EMBx procedure are known to be tran-
sient and without any significant hemodynamic consequences.
One case of asymptomatic and persistent right bundle branch
block developed after the EMBx in this study. Although most
conduction abnormalities have a benign course, the operator
must be prepared for the abrupt development of complete
heart block in the case of a preexisting left bundle branch
block.
The fourth category of complications includes mechanical
damage to the heart structures such as injury to the tricuspid
valve and perforation of the heart or central veins. Right ven-
tricular pseudoaneurysms (15), coronary artery to right ven-
tricular fistulas (16), and atrioventricular fistulas (17) have
also been reported. Several reports have described the devel-
opment of tricuspid regurgitation after an EMBx in heart
transplant recipients (18-21). In heart transplant recipients,
the EMBx is usually performed repeatedly for the early detec-
tion of a graft rejection and the number of EMBx procedures
is known to be directly related to the occurrence of significant
tricuspid regurgitation, especially if the EMBx is performed
under fluoroscopic guidance only (2, 18, 20). No significant
tricuspid regurgitation was observed in our series since EMBx
was performed only once and under the guidance with both
fluoroscopy and 2-D echocardiography. We paid great care
to avoid any damage to the tricuspid valve by the bioptome
manipulation. Even the sheath was inserted slowly over the
wire to pass the tricuspid valve while the dilator was some-
what withdrawn into the sheath to reduce the possibility of
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cases, we also shaped the sheath into a more suitable form to
pass across the tricuspid valve without any damage to valvu-
lar structure. We think that 2-D echocardiography was espe-
cially useful in guiding the passage of the sheath across the
tricuspid valve without any damage to the valvular and sub-
valvular structures. 
Right ventricular free wall perforations and resultant peri-
cardial effusion, tamponade or death remain the most con-
cerning complications of EMBx procedures (1-4, 13). In the
survey of 1,591 biopsies, of which 445 were done solely with
echocardiographic guidance, Ragni et al. reported only 2 cases
of right ventricular perforations (0.13%) with both occurring
during fluoroscopic guidance (1), which suggests the improv-
ed safety of 2-D echocardiography guided EMBx to conven-
tional fluoroscopy-guided EMBx. In our series, 3 out of 90
patients developed pericardial effusions, however, none pro-
gressed to cardiac tamponade or death. The interventricular
septum has been known to be the safest part of the right ven-
tricle for an EMBx, however, it is also known to usually be
spared from any fibro-fatty replacement associated with AR-
VD (6). Therefore, we selected to use the right ventricular
outflow tract and right ventricular apex for the biopsy site
in some cases to improve the diagnostic sensitivity in such
cases. One of those 5 patients in whom the EMBx was per-
formed from the right ventricular outflow tract developed
pericardial effusion. However, perforations also occurred when
the EMBx was performed mainly from the right ventricular
septum (n=2). Although the perforations occurred only in
patients with ARVD (n=2) or Brugada syndrome (n=1), we
think that the biopsy site was more important than the dis-
ease entity in order to predict a perforation for a few reasons.
First, our study group was mainly composed of patients with
suspected ARVD or Brugada syndrome, and therefore per-
forations occurred mainly in those 2 groups. Secondly, the
EMBx was intentionally performed from the right ventricu-
lar outflow tract and right ventricular apex, where the risk
of perforation is known to be higher than that of the septum,
in order to increase the diagnostic sensitivity. Two perfora-
tions, in which the septum was the primary site for the biop-
sy, might be related to the other possible technical causes
such as taking an EMBx from the septal-free wall junction,
excessive push applied to the bioptome, or too large size of a
sample removed (1, 10). The number of cases presented in
this study may not have been large enough to assess the risk
of perforation according to the type of cardiac pathology. A
larger series comparing the risk of perforations among diverse
cardiac pathologies may be required. Although complete pre-
vention of perforations was not feasible, we could easily detect
the perforations as accumulating pericardial effusions in the
early stages by 2-D echocardiography. Two-D echocardiog-
raphy was also useful for close monitoring of the pericardial
effusions.
Several minor abnormalities also occurred after the EMBx
procedures. In our experience, most of those symptoms and
signs were transient without any sequelae. However, great
care must be paid to those minor abnormalities to determine
whether or not they are truly insignificant abnormalities or
omens of grave complications.
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